Docoh
Loading...

Filter options loading...
Top filers
Top filing types
Recent filing years
10-K
2020 FY
PCSA Processa Pharmaceuticals Inc
24 Mar 21
Annual report
8:00pm
countries, the proposed pricing for a drug must be approved before it may be lawfully marketed. The requirements governing drug pricing and reimbursement … drug reimbursement policies, drug pricing and contracting practices, or government drug price regulation programs such as the Medicaid Drug Rebate
424B4
PCSA Processa Pharmaceuticals Inc
5 Oct 20
Prospectus supplement with pricing info
4:16pm
governments may adopt policies affecting drug pricing and contracting practices outside of the context of federal programs such as Medicare … changes to Medicare and/or Medicaid prescription drug reimbursement policies, drug pricing and contracting practices, or government drug price
S-1/A
PCSA Processa Pharmaceuticals Inc
30 Sep 20
IPO registration (amended)
4:06pm
affecting drug pricing and contracting practices outside of the context of federal programs such as Medicare and Medicaid, which may adversely affect our … prescription drug reimbursement policies, drug pricing and contracting practices, or government drug price regulation programs such as the Medicaid
S-1/A
PCSA Processa Pharmaceuticals Inc
16 Sep 20
IPO registration (amended)
8:00pm
and contracting may adversely affect our business and future prospects. Federal and state governments may adopt policies affecting drug pricing … policies, drug pricing and contracting practices, or government drug price regulation programs such as the Medicaid Drug Rebate Program or 340B Drug
S-1/A
PCSA Processa Pharmaceuticals Inc
17 Jul 20
IPO registration (amended)
5:25pm
, in most foreign countries, the proposed pricing for a drug must be approved before it may be lawfully marketed. The requirements governing drug pricing … in the 340B drug pricing program. The required 340B discount on a given product is calculated based on the AMP and Medicaid rebate amounts reported
10-K
2019 FY
PCSA Processa Pharmaceuticals Inc
5 Mar 20
Annual report
7:00pm
countries, the proposed pricing for a drug must be approved before it may be lawfully marketed. The requirements governing drug pricing … programs or to be sold directly to U.S. government agencies, the manufacturer must extend discounts to entities eligible to participate in the 340B drug
S-1
PCSA Processa Pharmaceuticals Inc
13 Dec 19
IPO registration
5:32pm
, the proposed pricing for a drug must be approved before it may be lawfully marketed. The requirements governing drug pricing and reimbursement vary … or to be sold directly to U.S. government agencies, the manufacturer must extend discounts to entities eligible to participate in the 340B drug pricing
8-K/A
PCSA Processa Pharmaceuticals Inc
16 Oct 17
Entry into a Material Definitive Agreement
8:00pm
marketed. The requirements governing drug pricing vary widely from country to country. Therefore, we may not successfully conclude the necessary processes … be approved before it may be lawfully marketed. The requirements governing drug pricing vary widely from country to country. Therefore, we may not successfully
8-K
PCSA Processa Pharmaceuticals Inc
11 Oct 17
Entry into a Material Definitive Agreement
8:00pm
, the proposed pricing for a drug must be approved before it may be lawfully marketed. The requirements governing drug pricing vary widely from … be approved before it may be lawfully marketed. The requirements governing drug pricing vary widely from country to country. Therefore, we may
  • 1